Hi, today we are going to talk about Children's Place and its current landscape. The American specialty retailer of children’s apparel and accessories Children's Place it's been crushed by a series of bad confluences, starting by the company report that showed a worse than expected EPS on the third quarterly, the company also issued a worse than expected EPS and...
Hi, today we are going to talk about VistaGen Therapeutics Inc and its current landscape. VistaGen Therapeutics Inc despite the high volatility of this penny stock it could be hiding a gold mine as the company has received Fast Track designation by the FDA for the development of the company's PH94B neuroactive nasal spray for on-demand treatment of social...
Hi, today we are going to talk about Achieve Life Sciences and its current landscape. Achieve Life Sciences has been surrounded by increasing speculation over its shares after a couple of days ago had unveiled an update on the cytisinicline (a drug to aid smoking cessation ) clinical development program, as the FDA had agreed with the overall Phase 3 study...
Hi, today we are going to talk about Francescas Holdings Corp and its current landscape. After reported a worse than expected EPS ( - $1.12) and sales results ($95.5 million miss the $119.31 million estimate) Francescas Holdings Corp has been under a bad momentum as investors got disappointed over the holding that operates a chain of retail boutiques that it...
Hi, today we are going to talk about LMP Automotive Holdings and its current landscape. LMP Automotive Holdings has been facing high volatile after its $13.2 million IPO on Dec. 5, since then the company shares have raised almost 300%, the company founded in 2017 that is an e-commerce platform for buying, selling and finance used cars, now with fresh funds the...
Hi, today we are going to talk about Technical Communications Corporation and its current landscape. Technical Communications Corporation it's under market attention after its much better than expected earnings report, where the company informed this quarter an EPS of $0.56, which represents a growth of 366.67 % from the same period last year when the company...
Hi, today we are going to talk about GBP USD and its current landscape. The Pound sterling enters on the spotlight of the market, as the U.K election nears its final moments, with the Conservative Party led by Boris Jhonson poised to get it's so wanted majority at the U.K Parliament, which would facilitate Conservatives plans to deliver Brexit before the deadline...
Hi, today we are going to talk about Fetch.ai and its current landscape. It's of common knowledge among those who observe the cryptocurrency market for a while that this market can be unpredictable and extremely volatile. Even senior traders have stories to tell about gains and losses, due to incredible surges or horrific slumps of the price, learning a...
Hi, today we are going to talk about Ravencoin and its current landscape. It's of common knowledge among those who observe the cryptocurrency market for a while that this market can be unpredictable and extremely volatile. Even senior traders have stories to tell about gains and losses, due to incredible surges or horrific slumps of the price, learning a...
Hi, today we are going to talk about Harmony and its current landscape. It's of common knowledge among those who observe the cryptocurrency market for a while that this market can be unpredictable and extremely volatile. Even senior traders have stories to tell about gains and losses, due to incredible surges or horrific slumps of the price, learning a complicated...
Hi, today we are going to talk about Matic Network and its current landscape. It's of common knowledge among those who observe the cryptocurrency market for a while that this market can be unpredictable and extremely volatile. Even senior traders have stories to tell about gains and losses, due to incredible surges or horrific slumps of the price, learning a...
Hi, today we are going to talk about Merck & Co. and its current landscape. Merck & Co. shares are in evidence today as was unveiled that the company it's going to acquire ArQule for $20 per share in cash, totalizing a deal of $2.7 billion. In this season of Mergers and Acquisitions, the Merck & Co. move is based on its interest in pushing its already established...
Hi, today we are going to talk about Veracity Inc and its current landscape. The American insurance company has sharply slumped after announced a special One- Time cash distribution, of $6.25 per share for common stockholders that had the shares until Nov. 21, that was paid in Dec. 06, which implies now in a continuous decrease of interessing over Delaware...
Hi, today we are going to talk about Precision BioSciences and its current landscape. Precision BioSciences, the genome editing company has received attention lately as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that...
Hi, today we are going to talk about Advaxis and its current landscape. Advaxis company receives attention today as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic movements on the oncology sector....
Hi, today we are going to talk about Diplomat Pharmacy and its current landscape. Diplomat Pharmacy company receives attention today as in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic movements on the oncology sector. Diplomat...
Hi, today we are going to talk about Fate Therapeutics and its current landscape. Fate Therapeutics company receives attention today as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic movements on...
Hi, today we are going to talk about Neoleukin Therapeutics and its current landscape. Neoleukin Therapeutics company receives attention today as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic...